Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major

References

• Origa R. β-Thalassemia. Genet Med. 2017;19(6):609–619. doi:10.1038/gim.2016.17327811859
   PubMed Web of Science ®Google Scholar
• Taghizadeh Sarvestani R, Moradveisi B, Kompany F, Ghaderi E. Correlation between heart and liver iron levels measured by MRI T2* and serum ferritin in patients with β-thalassemia major. Int J Pediatr. 2016;4(3):1559–1567. doi:10.22038/ijp.2016.6587
   Google Scholar
• Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y. Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol. 2010;56(13):1001–1012. doi:10.1016/j.jacc.2010.03.08320846597
   PubMed Web of Science ®Google Scholar
• Pennell DJ, Porter JB, Piga A, et al. Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine. Am J Hematol. 2015;90(2):91–96. doi:10.1002/ajh.2387625345697
   PubMed Web of Science ®Google Scholar
• Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson. 2006;8(3):543–547. doi:10.1080/1097664060069815516755844
   PubMed Web of Science ®Google Scholar
• Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood. 2004;103(5):1934–1936. doi:10.1182/blood-2003-06-191914630822
   PubMed Web of Science ®Google Scholar
• Aessopos A, Fragodimitri C, Karabatsos F, et al. Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. Haematologica. 2007;92(1):131–132. doi:10.3324/haematol.1045517229649
   PubMed Web of Science ®Google Scholar
• Voskaridou E, Douskou M, Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol. 2004;126(5):736–742. doi:10.1111/j.1365-2141.2004.05104.x15327528
   PubMed Web of Science ®Google Scholar
• Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol. 2005;75(3):241–247. doi:10.1111/j.1600-0609.2005.00474.x16104881
   PubMed Web of Science ®Google Scholar
• Pennell DJ, Udelson JE, Arai AE, et al. Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128(3):281–308. doi:10.1161/CIR.0b013e31829b2be623775258
   PubMed Web of Science ®Google Scholar
• Wahidiyat PA, Liauw F, Sekarsari D, Putriasih SA, Berdoukas V, Pennell DJ. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging. Hematology. 2017;22(8):501–507. doi:10.1080/10245332.2017.129261428218005
   PubMed Web of Science ®Google Scholar
• Youssef DM, Fawzy Mohammad F, Ahmed Fathy A, Aly Abdelbasset M. Assessment of hepatic and pancreatic iron overload in pediatric Beta-thalassemic major patients by t2* weighted gradient echo magnetic resonance imaging. ISRN Hematol. 2013;2013:496985. doi:10.1155/2013/49698523606980
   PubMedGoogle Scholar
• Soltanpour MS, Davari K. The correlation of cardiac and hepatic hemosiderosis as measured by T2*MRI technique with ferritin levels and hemochromatosis gene mutations in Iranian patients with beta thalassemia major. Oman Med J. 2018;33(1):48–54. doi:10.5001/omj.2018.0929467999
   PubMedGoogle Scholar
• Majd Z, Haghpanah S, Ajami GH, et al. Serum ferritin levels correlation with heart and liver MRI and LIC in patients with transfusion-dependent thalassemia. Iran Red Crescent Med J. 2015;17(4):0–3. doi:10.5812/ircmj.17(4)2015.24959
   Web of Science ®Google Scholar
• Eghbali A, TaheraAhmadi H, Shahbazi M, Bagheri B, Ebrahimi L. Association between serum ferritin level, cardiac and hepatic T2-star {MRI} in patients with major β-thalassemia. Iran J Ped Hematol Oncol. 2014;4(1):17–21.24734159
   PubMedGoogle Scholar
• Azarkeivan A, Hashemieh M, Shirkavand A, Sheibani K. Correlation between heart, liver and pancreas hemosiderosis measured by MRI T2* Among thalassemia major patients from Iran. Arch Iran Med. 2016;19(2):96–100. doi: 0161902/AIM.00626838079
   PubMed Web of Science ®Google Scholar
• He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurements in iron overloaded thalassemia. Magn Reson Med. 2008;60(5):1082–1089. doi:10.1002/mrm.21744.Myocardial18956471
   PubMed Web of Science ®Google Scholar
• Ghugre NR, Enriquez CM, Coates TD, Marvin DN Jr, Wood JC. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9–16.. doi:10.1002/jmri.20467.Improved
   Google Scholar
• Carpenter J, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation 2012;123(14):1519–1528. doi:10.1161/CIRCULATIONAHA.110.007641
   Google Scholar
• Garbowski MW, Carpenter JP, Smith G, et al. Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J Cardiovasc Magn Reson. 2014;16(1):1–11. doi:10.1186/1532-429X-16-4024387349
   PubMed Web of Science ®Google Scholar
• Bayraktaroǧlu S, Aydinok Y, Yildiz D, Uluer H, Savaş R, Alper H. T86. Diagnostic Interv Radiol. 2011;17(4):346–351. doi:10.4261/1305-3825.DIR.3933-10.2
   Web of Science ®Google Scholar
• Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci. 1998;850:191–201.9668540
   PubMed Web of Science ®Google Scholar
• Wood JC, Enriquez C, Ghugre N, et al. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N Y Acad Sci. 2005;1054:386–395. doi:10.1196/annals.1345.04716339687
   PubMed Web of Science ®Google Scholar
• Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis. Circulation. 1964;30:698–705. doi:10.1161/01.CIR.30.5.69814226168
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004;127(3):348–355. doi:10.1111/j.1365-2141.2004.05202.x15491298
   PubMed Web of Science ®Google Scholar
• Yuksel IO, Koklu E, Kurtoglu E, et al. The association between serum ferritin level, tissue doppler echocardiography, cardiac T2* MRI, and heart rate recovery in patients with beta thalassemia major. Acta Cardiol Sin. 2016;32(2):231–238. doi:10.6515/ACS20150824A27122954
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171–2179. doi:10.1053/euhj.2001.282211913479
   PubMed Web of Science ®Google Scholar
• Noetzli LJ, Carson SM, Nord AS, et al. Longitudinal analysis of heart and liver iron in thalassemia major longitudinal analysis of heart and liver iron in thalassemia major. October. 2008;112(7):2973–2978. doi:10.1182/blood-2008-04-148767
   Web of Science ®Google Scholar
• Marsella M, Borgna-Pignatti C, Meloni A, et al. Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study. Haematologica. 2011;96(4):515–520. doi:10.3324/haematol.2010.02551021228034
   PubMed Web of Science ®Google Scholar
• Yang G, Liu R, Peng P, et al. How early can myocardial iron overload occur in beta thalassemia major? PLoS One. 2014;9(1). doi:10.1371/journal.pone.0085379
   Web of Science ®Google Scholar
• Buja LM, Roberts WC. Iron in the heart. Etiology and clinical significance. Am J Med. 1971;51(2):209–221.5095527
   PubMed Web of Science ®Google Scholar
• Walker JM, Nair S. Detection of the cardiovascular complications of thalassemia by echocardiography. Ann N Y Acad Sci. 2010;1202:165–172. doi:10.1111/j.1749-6632.2010.05643.x20712789
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Cohen A, Eleftheriou A, et al. Thalassaemia International Federation; 2008. Guidelines for Clinical Management of Thalassaemia. 2nd Revised edition 2008.
   Google Scholar